MENU
+Compare
FMS
Stock ticker: NYSE
AS OF
Dec 24 closing price
Price
$24.05
Change
+$0.09 (+0.38%)
Capitalization
13.94B

FMS Fresenius Medical Care AG Forecast, Technical & Fundamental Analysis

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024... Show more

FMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for FMS with price predictions
Dec 24, 2025

FMS's RSI Oscillator recovers from oversold territory

The RSI Indicator for FMS moved out of oversold territory on December 10, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In of the 34 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 16, 2025. You may want to consider a long position or call options on FMS as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FMS just turned positive on November 25, 2025. Looking at past instances where FMS's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FMS advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FMS entered a downward trend on December 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.913) is normal, around the industry mean (8.177). P/E Ratio (16.714) is within average values for comparable stocks, (111.362). Projected Growth (PEG Ratio) (0.380) is also within normal values, averaging (1.943). Dividend Yield (0.034) settles around the average of (0.039) among similar stocks. P/S Ratio (0.608) is also within normal values, averaging (1.408).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

View a ticker or compare two or three
FMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

FMS is expected to report earnings to fall 49.28% to 55 cents per share on February 24

Fresenius Medical Care AG FMS Stock Earnings Reports
Q4'25
Est.
$0.56
Q3'25
Beat
by $0.53
Q2'25
Beat
by $0.41
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.26
The last earnings report on November 04 showed earnings per share of $1.10, beating the estimate of 56 cents. With 77.89K shares outstanding, the current market capitalization sits at 13.94B.
A.I.Advisor
published Dividends

FMS paid dividends on June 06, 2025

Fresenius Medical Care AG FMS Stock Dividends
А dividend of $0.79 per share was paid with a record date of June 06, 2025, and an ex-dividend date of May 23, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of renal and dialysis products

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
Else-Kroener-Strasse 1
Phone
+49 791033353
Employees
119845
Web
https://www.freseniusmedicalcare.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BUSA37.100.21
+0.57%
Brandes U.S. Value ETF
HECA28.430.10
+0.35%
Hedgeye Capital Allocation ETF
PREF19.150.06
+0.31%
Principal Spectrum Pref Secs Actv ETF
BRLN51.500.07
+0.15%
iShares Floating Rate Loan Active ETF
VNIE24.58N/A
N/A
Vontobel International Equity Active ETF

FMS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FMS has been loosely correlated with FSNUY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if FMS jumps, then FSNUY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FMS
1D Price
Change %
FMS100%
+0.38%
FSNUY - FMS
52%
Loosely correlated
+0.77%
DVA - FMS
38%
Loosely correlated
-0.27%
DNTCF - FMS
35%
Loosely correlated
N/A
CON - FMS
34%
Loosely correlated
+0.61%
ADUS - FMS
30%
Poorly correlated
+0.35%
More

Groups containing FMS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FMS
1D Price
Change %
FMS100%
+0.38%
Hospital/Nursing Management
industry (88 stocks)
25%
Poorly correlated
-0.46%